House Energy and Commerce Committee unanimously passed the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act yesterday, which NCPA applauds for its promise in a bipartisan package that’s endorsed by the full House of Representatives. H.R. 3561 includes several provisions vital to lowering prescription drug costs and bringing transparency to anticompetitive practices of pharmacy benefit managers. Find out which major provisions NCPA supported to make the PATIENT Act a success.
NCPA
